Daxor Corp
DX5
Company Profile
Business description
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Contact
109 Meco Lane
Oak RidgeTN37830
USAT: +1 212 330-8500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
750
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,690.90 | 53.40 | 0.62% |
| CAC 40 | 7,726.97 | 10.23 | -0.13% |
| DAX 40 | 23,969.55 | 38.88 | 0.16% |
| Dow JONES (US) | 42,305.48 | 35.41 | 0.08% |
| FTSE 100 | 8,785.74 | 11.48 | 0.13% |
| HKSE | 23,512.49 | 354.52 | 1.53% |
| NASDAQ | 19,242.61 | 128.85 | 0.67% |
| Nikkei 225 | 37,446.81 | 23.86 | -0.06% |
| NZX 50 Index | 12,327.23 | 91.66 | -0.74% |
| S&P 500 | 5,935.94 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,466.70 | 52.60 | 0.63% |
| SSE Composite Index | 3,361.98 | 14.49 | 0.43% |